Forgetting the fundoscope – A case of fulminant idiopathic intracranial hypertension causing rapid visual loss

Mulroy, Eoin; Krishnan, Thiyaga; Best, Stephen; Anderson, Neil E.

doi:10.1016/j.jocn.2018.01.031

Cited by 7 publications

(2 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Patients needed neurosurgical intervention experienced rapid disease progression with short HPT (fulminant IIH). This finding is passing with that of Hoffmann and colleagues 2018 [12] and Mulroy and colleagues 2018 [13] who stated that most IIH patients have a relatively benign, self-limiting course except in those with rapid progressive course and fast diminution of vision who carry worse visual outcomes and necessitate rapid CSF shunting.…”

Section: Discussionmentioning

confidence: 53%

Neuro-ophthalmological biomarkers of visual outcome in newly diagnosed idiopathic intracranial hypertension

Bahnasy

El-Heneedy

Elhassanien

et al. 2019

Egypt J Neurol Psychiatry Neurosurg

View full text Add to dashboard Cite

Background: Idiopathic intracranial hypertension (IIH) is a disorder of unidentified etiology characterized by raised intracranial pressure (ICP) without clinical, laboratory, or radiological evidence of intracranial pathology. The aim of this work was to determine the visual outcome in newly diagnosed IIH patients. Methods: The study included 68 IIH patients; 59 responded to medical treatment and nine needed lumboperitoneal shunting (LPS). Patients were submitted to papilledema grading using Frisén Scale, water CSF manometry, brain MRI/ MRV, mean deviation of visual field examination (MD-VFE), optic nerve sheath diameter (ONSD), average optic disc optical coherence tomography-retinal nerve fiber layer (OCT-RNFL) thickness, and pattern-reversal visual evoked potential (VEP). Results: Patients needed LPS showed statistically significant increase in baseline papilledema grade, MD-VFE, ONSD, average OCT-RNFL thickness, and P100 VEP latency. On the other hand, both studied groups showed statistically nonsignificant differences regarding the patients' ages and opening CSF pressure. Conclusion: Newly diagnosed IIH patients' evaluation must be based on multimodality neuro-ophthalmological assessment where papilledema grade, MD-VFE, and OCT-RNFL are valuable biomarkers of PVD while P100 VEP latency delay is a predictor of poor visual outcome and ONSD is an early indicator of elevated ICP regression after LPS surgery.

show abstract

Section: Discussionmentioning

confidence: 53%

Neuro-ophthalmological biomarkers of visual outcome in newly diagnosed idiopathic intracranial hypertension

Bahnasy

El-Heneedy

Elhassanien

et al. 2019

Egypt J Neurol Psychiatry Neurosurg

View full text Add to dashboard Cite

show abstract

“…The ability to obtain accurate fundoscopy exams and visual field testing is vital in Fulminant IIH cases. 9 …”

Section: Discussionmentioning

confidence: 99%

Acute presentation of idiopathic intracranial hypertension with severe vision deficits

Shaia

Elzie

2020

SAGE Open Medical Case Reports

View full text Add to dashboard Cite

Fulminant idiopathic intracranial hypertension is a rare presentation of idiopathic intracranial hypertension in which visual decline occurs within 4 weeks of initial symptom presentation. Idiopathic intracranial hypertension usually presents with headaches, visual disturbances, and in women who are overweight. We present a case of idiopathic intracranial hypertension in which a female patient presented with rapid, severe vision loss within 8 days of symptom presentation and no other idiopathic intracranial hypertension symptoms. This case highlights a rare presentation of Fulminant idiopathic intracranial hypertension and the need for a quick diagnosis and treatment to preserve vision.

show abstract

Papilledema

Wang¹

2018

Emergency Neuro-Ophthalmology

View full text Add to dashboard Cite

Forgetting the fundoscope – A case of fulminant idiopathic intracranial hypertension causing rapid visual loss

Cited by 7 publications

References 7 publications

Neuro-ophthalmological biomarkers of visual outcome in newly diagnosed idiopathic intracranial hypertension

Neuro-ophthalmological biomarkers of visual outcome in newly diagnosed idiopathic intracranial hypertension

Acute presentation of idiopathic intracranial hypertension with severe vision deficits

Papilledema

Contact Info

Product

Resources

About